Promising Penny Stocks On US Exchanges In November 2024

Simply Wall St.11-01

As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2480090281?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab","is_english":true,"pubTime":"2024-11-01 08:04","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2480090281","market":"us","top_or_hot":-1,"title":"Promising Penny Stocks On US Exchanges In November 2024","media":"Simply Wall St.","content":"<div>\n<p>As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In...</p>\n\n<a href=\"https://finance.yahoo.com/news/promising-penny-stocks-us-exchanges-000448588.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Promising Penny Stocks On US Exchanges In November 2024</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPromising Penny Stocks On US Exchanges In November 2024\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-01 08:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/promising-penny-stocks-us-exchanges-000448588.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In...</p>\n\n<a href=\"https://finance.yahoo.com/news/promising-penny-stocks-us-exchanges-000448588.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4526","symbol_name":"热门中概股","start_time":0,"source_url":"https://finance.yahoo.com/news/promising-penny-stocks-us-exchanges-000448588.html","article_id":"2480090281","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DGkyMqml3gFWOGvNtEHcnA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2480090281","pubTimestamp":1730419488,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In light of these market fluctuations, investors may find opportunities in lesser-known areas such as penny stocks—stocks often associated with smaller or newer companies that can still offer surprising value despite their outdated moniker. By focusing on those with solid financial foundations and potential for growth, investors might uncover promising opportunities among these overlooked stocks.Codexis, Inc., with a market cap of US$226.26 million, operates in the biotechnology sector generating US$60.89 million in revenue. Despite being unprofitable and experiencing increased losses over five years, Codexis maintains more cash than total debt and has sufficient cash runway for 2.7 years if free cash flow trends continue. Recent strategic moves include a non-exclusive licensing agreement wi","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4526":"热门中概股","BK4213":"石油与天然气的勘探与生产","BK4075":"烟草","BK4139":"生物科技","PVL":"Enduro Royalty Trust","BK4209":"餐馆","BABB":"BAB, Inc.","BK4551":"寇图资本持仓","RLX":"雾芯科技","BK4584":"避孕概念","BK4563":"昨日强势股","OSUR":"奥瑞许科技","GBIO":"Generation Bio Co.","ARC":"美国图文公司","CDXS":"Codexis","BK4143":"办公服务与用品"},"translate_title":"2024年11月美国交易所有前途的细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARC":1,"BABB":1,"PVL":1,"RLX":1,"CDXS":0.9,"GBIO":0.9,"OSUR":0.9},"content_text":"As October 2024 came to a close, major U.S. indices like the S&P 500, Nasdaq, and Dow Jones Industrial Average posted losses for the month, driven by disappointing earnings from big tech companies. In light of these market fluctuations, investors may find opportunities in lesser-known areas such as penny stocks—stocks often associated with smaller or newer companies that can still offer surprising value despite their outdated moniker. By focusing on those with solid financial foundations and potential for growth, investors might uncover promising opportunities among these overlooked stocks.\nTop 10 Penny Stocks In The United States\n\n\n\nName\nShare Price\nMarket Cap\nFinancial Health Rating\n\n\nBAB (OTCPK:BABB)\n$0.799\n$5.75M\n★★★★★★\n\n\nLexinFintech Holdings (NasdaqGS:LX)\n$3.175\n$534.34M\n★★★★★★\n\n\nRLX Technology (NYSE:RLX)\n$1.62\n$2.12B\n★★★★★★\n\n\nPermianville Royalty Trust (NYSE:PVL)\n$1.55\n$50.82M\n★★★★★★\n\n\nGolden Growers Cooperative (OTCPK:GGRO.U)\n$4.50\n$69.71M\n★★★★★★\n\n\nMIND C.T.I (NasdaqGM:MNDO)\n$1.88\n$39.56M\n★★★★★★\n\n\nARC Document Solutions (NYSE:ARC)\n$3.36\n$147.91M\n★★★★★★\n\n\nCommercial Vehicle Group (NasdaqGS:CVGI)\n$2.91\n$99.68M\n★★★★★☆\n\n\nCBAK Energy Technology (NasdaqCM:CBAT)\n$1.05\n$98.93M\n★★★★★☆\n\n\nSo-Young International (NasdaqGM:SY)\n$1.25\n$97.93M\n★★★★☆☆\n\n\n\nClick here to see the full list of 756 stocks from our US Penny Stocks screener.\nWe'll examine a selection from our screener results.\nCodexis\nSimply Wall St Financial Health Rating: ★★★★★☆\nOverview: Codexis, Inc. is a company that discovers, develops, and sells enzymes and other proteins with a market cap of $226.26 million.\nOperations: The biotechnology segment generated $60.89 million in revenue.\nMarket Cap: $226.26M\nCodexis, Inc., with a market cap of US$226.26 million, operates in the biotechnology sector generating US$60.89 million in revenue. Despite being unprofitable and experiencing increased losses over five years, Codexis maintains more cash than total debt and has sufficient cash runway for 2.7 years if free cash flow trends continue. Recent strategic moves include a non-exclusive licensing agreement with Alphazyme LLC to enhance enzyme commercialization and capital raises totaling US$31 million to bolster its financial position. The management team has been strengthened with new appointments, indicating a focus on future growth initiatives despite current challenges.\n\nNavigate through the intricacies of Codexis with our comprehensive balance sheet health report here.\nReview our growth performance report to gain insights into Codexis' future.\n\n\n\n\n  NasdaqGS:CDXS Financial Position Analysis as at Nov 2024\n \n\nGeneration Bio\nSimply Wall St Financial Health Rating: ★★★★★★\nOverview: Generation Bio Co. focuses on developing non-viral genetic medicines to treat rare and prevalent diseases, with a market cap of approximately $159.51 million.\nOperations: The company generates revenue from its Pharmaceuticals segment, amounting to $13.17 million.\nMarket Cap: $159.51M\nGeneration Bio Co., with a market cap of US$159.51 million, is focused on developing non-viral genetic medicines. Despite being unprofitable and not expected to achieve profitability soon, it maintains strong financial health with short-term assets exceeding both short and long-term liabilities, and no debt burden. The company has a cash runway for 2.8 years if free cash flow continues to decrease at historical rates. Recent developments include promising data from its collaboration with Moderna on ctLNP and iqDNA platforms, which were presented at the ESGCT Congress, highlighting potential advancements in gene therapy delivery methods.\n\nClick here and access our complete financial health analysis report to understand the dynamics of Generation Bio.\nAssess Generation Bio's future earnings estimates with our detailed growth reports.\n\n\n\n\n  NasdaqGS:GBIO Debt to Equity History and Analysis as at Nov 2024\n \n\nOraSure Technologies\nSimply Wall St Financial Health Rating: ★★★★★★\nOverview: OraSure Technologies, Inc. operates in the healthcare sector by offering point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory services globally, with a market cap of approximately $317.66 million.\nOperations: The company's revenue is primarily derived from its Diagnostics and Molecular Solutions segment, which generated $273.54 million.\nMarket Cap: $317.66M\nOraSure Technologies, Inc., with a market cap of US$317.66 million, operates in the healthcare sector offering diagnostic solutions. Despite recent revenue declines to US$54.34 million in Q2 2024 from US$85.44 million a year ago, the company remains debt-free with short-term assets exceeding liabilities significantly. Its net profit margin has improved slightly over the past year despite large one-off losses impacting financial results. Recent strategic moves include board expansion and filing for a $12.66 million shelf registration, indicating potential capital raising activities which could support future growth initiatives amidst challenging earnings forecasts.\n\nTake a closer look at OraSure Technologies' potential here in our financial health report.\nExplore OraSure Technologies' analyst forecasts in our growth report.\n\n\n\n\n  NasdaqGS:OSUR Financial Position Analysis as at Nov 2024\n \n\nSumming It All Up\n\nJump into our full catalog of 756  US Penny Stocks here.\nShareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.\nMaximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.\n\nContemplating Other Strategies?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nJump on the AI train with fast growing tech companies forging a new era of innovation.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqGS:CDXS NasdaqGS:GBIO and NasdaqGS:OSUR.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2480090281"}